184 related articles for article (PubMed ID: 25077623)
1. Feedback from a European Bioanalysis Forum survey on bioanalysis of drugs in tissues.
Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lenthéric I; McIntosh M; Dzygiel P; Timmerman P
Bioanalysis; 2014; 6(12):1617-26. PubMed ID: 25077623
[TBL] [Abstract][Full Text] [Related]
2. Recommendations from the European Bioanalysis Forum on method establishment for tissue homogenates.
Timmerman P; Mokrzycki N; Delrat P; De Meulder M; Erbach E; Lentheric I; McIntosh M; Dzygiel P
Bioanalysis; 2014; 6(12):1647-56. PubMed ID: 25077625
[TBL] [Abstract][Full Text] [Related]
3. European Bioanalysis Forum: recommendation for dealing with internal standard variability.
White S; Adcock N; Elbast W; Hiller J; Knutsson M; Lausecker B; Long J; McDougall S; Salavert F; Sangster T; Verhaeghe T; van Amsterdam P
Bioanalysis; 2014 Oct; 6(20):2767-74. PubMed ID: 25413707
[TBL] [Abstract][Full Text] [Related]
4. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation.
van Amsterdam P; Companjen A; Brudny-Kloeppel M; Golob M; Luedtke S; Timmerman P
Bioanalysis; 2013 Mar; 5(6):645-59. PubMed ID: 23484783
[TBL] [Abstract][Full Text] [Related]
5. European Bioanalysis Forum recommendation on method establishment and bioanalysis of biomarkers in support of drug development.
Timmerman P; Herling C; Stoellner D; Jaitner B; Pihl S; Elsby K; Henderson N; Barroso B; Fischmann S; Companjen A; Versteilen A; Bates S; Kingsley C; Kunz U;
Bioanalysis; 2012 Aug; 4(15):1883-94. PubMed ID: 22943619
[TBL] [Abstract][Full Text] [Related]
6. European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period.
Timmerman P; Goodman J; Golob M; Haslberger T; Knutsson M; Nelson R; Verhaeghe T; White S
Bioanalysis; 2020 Mar; 12(6s):1-11. PubMed ID: 32323555
[TBL] [Abstract][Full Text] [Related]
7. Best practices in a tiered approach to metabolite quantification: views and recommendations of the European Bioanalysis Forum.
Timmerman P; Anders Kall M; Gordon B; Laakso S; Freisleben A; Hucker R
Bioanalysis; 2010 Jul; 2(7):1185-94. PubMed ID: 21083233
[TBL] [Abstract][Full Text] [Related]
8. Workshop/conference report on EMA draft guideline on validation of bioanalytical methods.
Blume H; Brendel E; Brudny-Klöppel M; Grebe S; Lausecker B; Rohde G; Siethoff C
Eur J Pharm Sci; 2011 Feb; 42(3):300-5. PubMed ID: 21185936
[TBL] [Abstract][Full Text] [Related]
9. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.
Higton D; Young G; Timmerman P; Abbott R; Knutsson M; Svensson LD
Bioanalysis; 2012 Nov; 4(22):2669-79. PubMed ID: 23210650
[TBL] [Abstract][Full Text] [Related]
10. Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
Timmerman P; Luedtke S; van Amsterdam P; Brudny-Kloeppel M; Lausecker B; Fischmann S; Globig S; Sennbro CJ; Jansat JM; Mulder H; Thomas E; Knutsson M; Kasel D; White SA; Kall MA; Mokrzycki-Issartel N; Freisleben A; Romero F; Andersen MP; Knebel N; de Zwart M; Laakso S; Hucker RS; Schmidt D; Gordon B; Abbott R; Boulanger P
Bioanalysis; 2009 Sep; 1(6):1049-56. PubMed ID: 21083073
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulant counter ion impact on bioanalytical LC-MS/MS assays: results from discussions and experiments within the European Bioanalysis Forum.
Sennbro CJ; Knutsson M; van Amsterdam P; Timmerman P
Bioanalysis; 2011 Nov; 3(21):2393-9. PubMed ID: 22074281
[TBL] [Abstract][Full Text] [Related]
12. Managing scientific, technical and regulatory innovation in regulated bioanalysis: a discussion paper from the European Bioanalysis Forum.
Timmerman P; Henderson N; Smeraglia J; Mulder H; Ingelse B; Brudny-Kloeppel M; Companjen A
Bioanalysis; 2013 Jan; 5(2):139-45. PubMed ID: 23330557
[TBL] [Abstract][Full Text] [Related]
13. EBF recommendation on the validation of bioanalytical methods for dried blood spots.
Timmerman P; White S; Globig S; Lüdtke S; Brunet L; Smeraglia J
Bioanalysis; 2011 Jul; 3(14):1567-75. PubMed ID: 21749218
[TBL] [Abstract][Full Text] [Related]
14. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
[TBL] [Abstract][Full Text] [Related]
15. Bioanalysis for plasma protein binding studies in drug discovery and drug development: views and recommendations of the European Bioanalysis Forum.
Buscher B; Laakso S; Mascher H; Pusecker K; Doig M; Dillen L; Wagner-Redeker W; Pfeifer T; Delrat P; Timmerman P
Bioanalysis; 2014 Mar; 6(5):673-82. PubMed ID: 24620809
[TBL] [Abstract][Full Text] [Related]
16. EBF: reflection on bioanalytical assay requirements used to support liquid microsampling.
White S; Hawthorne G; Dillen L; Spooner N; Woods K; Sangster T; Cobb Z; Timmerman P
Bioanalysis; 2014; 6(19):2581-6. PubMed ID: 25411700
[No Abstract] [Full Text] [Related]
17. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis.
Freisleben A; Brudny-Klöppel M; Mulder H; de Vries R; de Zwart M; Timmerman P
Bioanalysis; 2011 Jun; 3(12):1333-6. PubMed ID: 21679027
[TBL] [Abstract][Full Text] [Related]
18. European Bioanalysis Forum: recommendation on dealing with hemolyzed and hyperlipidemic matrices.
Ingelse B; Barroso B; Gray N; Jakob-Rodamer V; Kingsley C; Sykora C; Vinck P; Wein M; White S
Bioanalysis; 2014; 6(23):3113-20. PubMed ID: 25529880
[TBL] [Abstract][Full Text] [Related]
19. Best practices for metabolite quantification in drug development: updated recommendation from the European Bioanalysis Forum.
Timmerman P; Blech S; White S; Green M; Delatour C; McDougall S; Mannens G; Smeraglia J; Williams S; Young G
Bioanalysis; 2016 Jun; 8(12):1297-305. PubMed ID: 27217058
[TBL] [Abstract][Full Text] [Related]
20. Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis.
Laurén A; Braun M; Cazzin C; Colleti K; Cox C; Dietz L; Emrich T; Geddes K; Herr K; Iles T; Rogue A; Verlinden Y; Timmerman P
Bioanalysis; 2022 Aug; 14(16):1085-1093. PubMed ID: 36125042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
